You are not logged in so some information on this page has been withheld. To see more, please log in.

Alzheimer´s drugs rejected for NHS because benefits...

found 2025 › Jun › 19 (Thu) @ 00:10 UTC

a story from The Daily Mail 💩 › The Daily Mail

NHS ■■■
National Institute ■■
Health ■■
Care Excellence ■■

The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and lecanemab after considering new information.